Search tool

Cover of the risk assessment

Risk assessments

Report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil) in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. In March 2018...

Cover of the risk assessment

Risk assessments

Report on the risk assessment of methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA) in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on methyl 2-{[1-(5-fluoropentyl)-1 H -indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. In...

Cover of the AB-CHMINACA risk assessment

Risk assessments

Report on the risk assessment of N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on N -(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1 H -indazole-3-carboxamide (AB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. In...

Cover of the risk assessment

Risk assessments

Report on the risk assessment of N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF) in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on N -(4-fluorophenyl)-2-methyl- N -[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. In...

Cover of the risk assessment

Risk assessments

Report on the risk assessment of N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]oxolane-2-carboxamide (THF-F) in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on N -phenyl- N -[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (THF-F), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. In...

EMCDDA publishes latest insights into NPS in Europe

In a new update from the EU Early Warning System (EWS) on new psychoactive substances (NPS) ( 1 ), the EMCDDA releases today its latest insights in this area entitled Fentanils and...

Rapid communication

Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation — an update from the EU Early Warning System

In this update from the EU Early Warning System, the EMCDDA aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency’s early...

Chart showing number and quantity of seizures of new psychoactive substance reported to the EU Early Warning System: trends and distribution by category in 2016

Infographic: number and quantity of seizures of new psychoactive substance reported to the EU Early Warning System: trends and distribution by category in 2016

Chart showing number of different fentanils detected by country reported to the EU Early Warning System, 2012-17

Infographic: number of different fentanils detected by country reported to the EU Early Warning System, 2012-17

Chart showing seizures of fentanils reported to the EU Early Warning System: trends in number of seizures and quantity detected, 2012-16

Infographic: seizures of fentanils reported to the EU Early Warning System: trends in number of seizures and quantity detected, 2012-16